BIM
ARRY

Bogle Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Bogle Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-366,626
Closed -$5.98M – 390
2018
Q1 		$5.98M Buy
+366,626
New +$5.87M 0.45% 88
2017
Q2 		– Sell
-1,995,880
Closed -$17.8M – 422
2017
Q1 		$17.8M Sell
1,995,880
-77,800
-4% -$828K 1.24% 7
2016
Q4 		$18.2M Buy
2,073,680
+796,466
+62% +$5.86M 1.26% 4
2016
Q3 		$8.62M Buy
+1,277,214
New +$4.94M 0.62% 64
2016
Q1 		– Sell
-211,714
Closed -$893K – 505
2015
Q4 		$893K Buy
+211,714
New +$966K 0.06% 278
2015
Q2 		– Sell
-1,450,173
Closed -$10.7M – 459
2015
Q1 		$10.7M Buy
+1,450,173
New +$10.3M 0.74% 45

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return